stella
beta
Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator — Stella
Recruiting
Back to Cardiogenic Shock trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
South Korea
Samsung Medical Center, Seoul
View full record on ClinicalTrials.gov